Health care utilization in HIV-infected patients: Assessing the burden of hepatitis C virus coinfection

AIDS Patient Care and STDs

Volumn 26, Issue 9, 2012, Pages 541-545

  Norton, Brianna L ^a   Park, Lawrence ^a   McGrath, Leah J ^b   Proeschold Bell, Rae Jean ^c   Muir, Andrew J ^d   Naggie, Susanna ^a,d  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b IL   (United States)

^c DUKE UNIVERSITY   (United States)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; DIABETES MELLITUS; EMERGENCY WARD; FEMALE; HEALTH CARE UTILIZATION; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MIXED INFECTION; RETROSPECTIVE STUDY; SUBSTANCE ABUSE; UNITED STATES;

ADULT; CARDIOVASCULAR DISEASES; COHORT STUDIES; COINFECTION; COMORBIDITY; DIABETES MELLITUS; EMERGENCY MEDICAL SERVICES; FEMALE; HEALTH RESOURCES; HEPATITIS C; HIV INFECTIONS; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; PATIENT ADMISSION; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 84865464500     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2012.0170     Document Type: Article

References (19)

1. Lavanchy D. The global burden of hepatitis C. Liver Int 2009;29(Suppl 1):74-81.
2. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR (in press
3. Sulkowski MS, Thomas DL. Hepatitis C in the HIV-infected patient. Clin Liver Dis 2003;7:179-194. (Pubitemid 36350759)
4. Wong JB, McQuillan GM, McHutchison JG, Poynard T: Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000;90:1562-1569.
5. Grant WC, Jhaveri RR, McHutchison JG, Schulman KA, Kauf TL. Trends in health care resource use for hepatitis C virus infection in the United States. Hepatology 2005;42: 1406-1413. (Pubitemid 43260044)
6. Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med 2012;156:271-278.
7. Crum-Cianflone NF, Grandits G, Echols S, et al. Trends and causes of hospitalizations among HIV-infected persons during the late HAART era: What is the impact of CD4 counts and HAART use? J Acquir Immune Defic Syndr 2010;54:248-257.
8. Linas BP, Wang B, Smurzynski M, et al. The impact of HIV/HCV co-infection on health care utilization and disability: Results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort. J Viral Hepat (in press
9. Nunez-Fernandez C, Martin-Carbonero L, Valencia ME, et al. Liver complications have reached a plateau as cause of hospital admission and death in HIV patients in Madrid. AIDS Res Hum Retroviruses 2009;25:383-385.
10. Martin-Carbonero L, Sanchez-Somolinos M, Garcia- Samaniego J, et al. Reduction in liver-related hospital admissions and deaths in HIV-infected patients since the year 2002. J Viral Hepat 2006;13:851-857. (Pubitemid 44748291)
11. Moore RD, Chaisson RE. Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS 1999;13: 1933-1942. (Pubitemid 29509554)
12. Palella FJ, Jr., Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006;43:27-34. (Pubitemid 44306484)
13. Kramer JR, Giordano TP, Souchek J, El-Serag HB. Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era. J Hepatol 2005;42: 309-314. (Pubitemid 40254243)
14. Weber R, Sabin CA, Friis-Moller N, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 2006;166: 1632-1641. (Pubitemid 44232373)
15. Qurishi N, Kreuzberg C, Luchters G, et al. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet 2003;362:1708-1713. (Pubitemid 37468321)
16. Tedaldi E, Peters L, Neuhaus J, et al. Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study. Clin Infect Dis 2008;47:1468-1475.
17. Angeli E, Mainini A, Meraviglia P, et al. Eligibility and feasibility of the treatment of chronic hepatitis C in a Cohort of Italian HIV-positive patients at a single HIV reference center. AIDS Patient Care STDs 2011;25:295-301.
18. Swan D, Long J, Carr O, et al. Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: A qualitative exploration. AIDS Patient Care STDs 2010;24:753-762.
19. Osilla KC, Wagner G, Garnett J, et al. Patient and provider characteristics associated with the decision of HIV coinfected patients to start hepatitis C treatment. AIDS Patient Care STDs 2011;25:533-538.